ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,352 | +14.1% | 22,444 | +29.7% | 0.01% | +16.7% |
| Q4 2022 | $701,688 | -53.3% | 17,300 | -61.9% | 0.01% | -53.8% |
| Q3 2022 | $1,502,000 | +311.5% | 45,422 | +338.4% | 0.01% | +225.0% |
| Q2 2022 | $365,000 | -54.9% | 10,361 | -41.1% | 0.00% | -42.9% |
| Q1 2022 | $809,000 | -35.1% | 17,600 | -6.3% | 0.01% | -36.4% |
| Q4 2021 | $1,246,000 | -20.8% | 18,787 | -1.1% | 0.01% | -35.3% |
| Q2 2021 | $1,573,000 | +524.2% | 18,996 | +399.8% | 0.02% | +466.7% |
| Q1 2021 | $252,000 | -78.6% | 3,801 | -75.2% | 0.00% | -81.2% |
| Q4 2020 | $1,176,000 | -12.6% | 15,321 | -51.0% | 0.02% | -38.5% |
| Q3 2020 | $1,346,000 | +20.8% | 31,251 | -61.8% | 0.03% | -56.7% |
| Q2 2018 | $1,114,000 | +129.7% | 81,900 | +21.8% | 0.06% | +66.7% |
| Q1 2018 | $485,000 | – | 67,257 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |